Individual results vary significantly
In the STEP-1 trial of 1,961 adults (Wilding and colleagues, Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021), participants on semaglutide 2.4 mg lost an average of 14.9 percent of their body weight at 68 weeks, compared to 2.4 percent on placebo
But they are not the same compound, and they do not work through the same Peptide research has grown fast over the past few years, and the BPC-157 vs TB-500 comparison comes up again and again
This vitamin is essential and can be found in many different types of foods that are available, but it is also offered as an injection for ease to take for your body to use faster
doi:10.1016/j.androl.2019.09.001